GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Molekule Group Inc (OTCPK:MKULQ) » Definitions » EBIT

Molekule Group (Molekule Group) EBIT : $-42.28 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Molekule Group EBIT?

Molekule Group's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2023 was $-23.62 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2023 was $-42.28 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Molekule Group's annualized ROC % for the quarter that ended in Jun. 2023 was -43.60%. Molekule Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -234.73%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Molekule Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -100.89%.


Molekule Group EBIT Historical Data

The historical data trend for Molekule Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molekule Group EBIT Chart

Molekule Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EBIT
-0.15 -3.32 -8.24 -17.29

Molekule Group Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.30 -5.05 -4.93 -8.69 -23.62

Competitive Comparison of Molekule Group's EBIT

For the Pollution & Treatment Controls subindustry, Molekule Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Molekule Group's EV-to-EBIT Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Molekule Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Molekule Group's EV-to-EBIT falls into.



Molekule Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-42.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Molekule Group  (OTCPK:MKULQ) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Molekule Group's annualized ROC % for the quarter that ended in Jun. 2023 is calculated as:

ROC % (Q: Jun. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2023 ) + Invested Capital (Q: Jun. 2023 ))/ count )
=-46.804 * ( 1 - 0.37% )/( (105.763 + 108.12)/ 2 )
=-46.6308252/106.9415
=-43.60 %

where

Note: The Operating Income data used here is four times the quarterly (Jun. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Molekule Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2023  Q: Jun. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-94.476/( ( (21.536 + max(17.744, 0)) + (19.578 + max(21.639, 0)) )/ 2 )
=-94.476/( ( 39.28 + 41.217 )/ 2 )
=-94.476/40.2485
=-234.73 %

where Working Capital is:

Working Capital(Q: Mar. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.014 + 29.692 + 2.473) - (15.435 + 0 + 0)
=17.744

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.211 + 29.433 + 2.431) - (12.051 + 0 + 0.385)
=21.639

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Molekule Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2023 )
=-42.277/41.904
=-100.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Molekule Group EBIT Related Terms

Thank you for viewing the detailed overview of Molekule Group's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Molekule Group (Molekule Group) Business Description

Traded in Other Exchanges
N/A
Address
10455 Riverside Drive, Palm Beach Gardens, FL, USA, 33410
Molekule Group Inc is an interior space air purification technology company with an immediate objective of initiating full-scale commercialization of its high-performance interior air sterilization and disinfection products for the eradication of coronavirus and other harmful airborne pathogens. The Company was established to develop technology-driven, medical-grade air purification solutions for hospitals and other healthcare settings. Its air hygiene product, Purgo, is an FD medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology that can be applied in any indoor space including in hospitals, offices, and even in elevators.
Executives
Ritankar Pal officer: Chief Operating Officer 10455 RIVERSIDE DR., PALM BEACH GARDENS FL 33410
Jonathan Harris officer: Chief Commercial Officer 3000 CLEARVIEW WAY, SAN MATEO CA 94402
Bradley A Feld director C/O FOUNDRY GROUP, 645 WALNUT ST., BOULDER CO 80302
Ryan A Mcintyre 10 percent owner
Seth Levine 10 percent owner 1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Fg Next Gp, Llc 10 percent owner 1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Foundry Group Next, L.p. 10 percent owner C/O FOUNDRY GROUP, 1050 WALNUT STREET, SUITE 219, BOULDER CO 80302
Ward Jr Stephen M director C/O CARPENTER TECHNOLOGY CORP, PO BOX 14662, READING PA 19612
Timothy J Scannell director 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Heather Floyd director 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Thomas P Mccaffrey director 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Lewis C Pell 10 percent owner C/O VISION SCIENCES INC, 6 STRATHMORE RD, NATICK MA 01760
Michael F Senft director 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Jason Dibona officer: Chief Executive Officer 10455 RIVERSIDE DRIVE, PALM BEACH GARDEN FL 33410
David Helfet director 10455 RIVERSIDE DRIVE, PALM BEACH GARDENS FL 33410